Original language | English (US) |
---|---|
Pages (from-to) | 867-868 |
Number of pages | 2 |
Journal | CHEST |
Volume | 161 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2022 |
Funding
FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: R. K. reports receiving personal fees from AstraZeneca, GlaxoSmithKline, Omron, and CVS Health, none related to the current work. None declared (J. I. B.).
ASJC Scopus subject areas
- Critical Care and Intensive Care Medicine
- Cardiology and Cardiovascular Medicine
- Pulmonary and Respiratory Medicine